NASDAQ:CNTX

Context Therapeutics Stock Predictions

etoro logo Buy CNTX
*Your capital is at risk
$2.05
-0.370 (-15.29%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

CNTX Prediction Chart

CNTX Predictions History

Latest community submissions for CNTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Jun 3, 2026 $2.35 -2.82% $2.05 V 85.28% 1
Jun 3, 2026 $2.50 +3.23% $2.05 X 78.14% 0
Jun 3, 2026 $2.47 +2.02% $2.05 X 79.57% 0
Jun 3, 2026 $3.20 +32.23% $2.05 X 43.90% 0
Jun 2, 2026 $2.86 +2.59% $2.42 X 81.72% 0
Jun 2, 2026 $2.86 +2.59% $2.42 X 81.72% 0
Jun 2, 2026 $2.74 -1.62% $2.42 V 86.58% 1
Jun 2, 2026 $3.00 +7.53% $2.42 X 76.03% 0
May 28, 2026 $3.10 +4.03% $2.83 X 90.46% 0
Mar 17, 2026 $3.18 +3.76% $2.86 X 88.98% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CNTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT CONTEXT THERAPEUTICS INC.
Context Therapeutics
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product candidate is onapristone extended release (ONA-XR), a potent and selective antagonist of the progesterone receptor that is linked to resistance for various classes of cancer therapeutics, such as anti-estrogen therapies across female hormone-dependent cancers. The company is also dev...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE